One-third of patients with type 2 diabetes prescribed metformin do not take their recommended doses, possibly because of adverse events related to the medication, according to findings published in Diabetes, Obesity and Metabolism.
“Nonadherence and nonpersistence with medications in type 2 diabetes are associated with worse outcomes, including poorer glycemic control, more complications and higher overall costs,” Andrew McGovern, BMBS, from the University of Surrey, England, and colleagues wrote. “Despite these adverse outcomes, a substantial proportion people with type 2
Original Article: One in three patients with type 2 diabetes fail to take medication
NEXT ARTICLE